David Belada
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 136
- Genetics 84
- Chronic Lymphocytic Leukemia Research 82
- Co-authors
- Marek Trněný (72 shared papers)Andrea Janíková (36 shared papers)Heidi Móciková (43 shared papers)Vít Procházka (38 shared papers)Robert Pytlík (32 shared papers)Lukáš Smolej (21 shared papers)Vít Campr (26 shared papers)Martin Šimkovič (16 shared papers)
- Journals
- Blood (44 papers)Hematological Oncology (19 papers)Journal of Clinical Oncology (17 papers)Annals of Hematology (6 papers)Leukemia Research (4 papers)
- Partner nations
- CzechiaUnited StatesSpain
In The Last Decade
David Belada
151 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 48
- Pathology and Forensic Medicine 793
- Genetics 307
- Oncology 544
- Neurology 157
- Immunology 152
Countries citing papers authored by David Belada
This map shows the geographic impact of David Belada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Belada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Belada more than expected).
Fields of papers citing papers by David Belada
This network shows the impact of papers produced by David Belada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Belada. The network helps show where David Belada may publish in the future.
Co-authors
The 25 scholars most cited alongside David Belada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 41 | |
| 2 | 2011 | 41 | |
| 3 | 2010 | 39 | |
| 4 | 2021 | 37 | |
| 5 | 2015 | 37 | |
| 6 | 2015 | 33 | |
| 7 | 2020 | 30 | |
| 8 | 2016 | 25 | |
| 9 | 2019 | 23 | |
| 10 | 2014 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2013 | 21 | |
| 13 | 2014 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2010 | 19 | |
| 17 | 2023 | 18 | |
| 18 | 2015 | 18 | |
| 19 | 2012 | 18 | |
| 20 | 2025 | 16 |
About David Belada
David Belada is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 169 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (136 papers), Chronic Lymphocytic Leukemia Research (82 papers), CAR-T cell therapy research (30 papers), Viral-associated cancers and disorders (27 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), CNS Lymphoma Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (793 citations), Genetics (307 citations), Oncology (544 citations), Neurology (157 citations) and Immunology (152 citations). David Belada has collaborated with scholars based in Czechia, United States and Spain. Frequent co-authors include Marek Trněný, Andrea Janíková, Heidi Móciková, Vít Procházka, Robert Pytlík, Lukáš Smolej, Vít Campr, Martin Šimkovič, Jiří Mayer and Jiřı́ Mayer. Their work appears in journals such as Blood, Hematological Oncology, Journal of Clinical Oncology, Annals of Hematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.